Delivery Order SPE2DB22D3501-SPE2DB25FWE99
Award Date
6/27/25
Potential Completion Date
6/30/25
Potential Value
$8.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $30,179.46. The contract is a firm fixed price delivery order with a period of performance through February 19, 2025. This award is part of a larger Indefinite Delivery...
This is a $13,191.68 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 200 mg/10 mL vials of the drug ACTEMRA. The contract has a ceiling value of $6,034.81 and a period of performance through June 5, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTEMRA 400 MG/20 ML vials. The contract has a ceiling value of $9,315.28 and an ultimate completion date of August 1, 2024. Amerisourcebergen is a large, for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract provides for the delivery of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, with a ceiling value of $14,090.74 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,471.52 and a period of performance through May 21, 2025. This award is not associated with a set-aside program and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,109,223 units of the pharmaceutical product ACTEMRA 400 MG/20 ML VIAL 20ML. The contract has a ceiling value of $11,253.17 and a period of performance through March 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 400 mg/20 mL vials of the drug ACTEMRA, with a ceiling value of $6,780.12 and a completion date of December 18, 2024. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,946.84, is a Delivery Order for the ACTEMRA 400 MG/20 ML VIAL 20ML pharmaceutical product. The contract has an ultimate completion date of November 4, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication, with a ceiling value of $19,787.52 and a period of performance through February 10, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...